Literature DB >> 8613431

Loss or somatic mutations of hMSH2 occur in hereditary nonpolyposis colorectal cancers with hMSH2 germline mutations.

S L Lu1, Y Akiyama, H Nagasaki, T Nomizu, E Ikeda, S Baba, K Ushio, T Iwama, K Maruyama, Y Yuasa.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is a major cancer susceptibility syndrome known to be caused by the inheritance of mutations in DNA mismatch repair genes, such as hMSH2, hMLH1, hPMS1 and hPMS2. To investigate the role of genetic alterations of hMSH2 in HNPCC tumorigenesis, we analyzed 36 Japanese HNPCC kindreds as to hMSH2 germline mutations. Moreover, we also examined somatic mutations of hMSH2 or loss of heterozygosity at or near the hMSH2 locus in the tumors from the hMSH2-related kindreds. Germline mutations were detected in five HNPCC kindreds (5/36, 14%). Among them, three were nonsense mutations, one was a frameshift mutation and the other was a mutation in an intron where the mutation affected splicing. Loss of heterozygosity in four and somatic mutations in one were detected among the eight tumors with hMSH2 germline mutations. All these alterations were only detected in genomic instability(+) tumors, i.e., not in genomic instability(-) ones, indicating that mutations of hMSH2 were responsible for at least some of the tumors with genomic instability. These data establish a basis for the presymptomatic diagnosis of HNPCC patients, and constitute further evidence that both DNA mismatch repair genes and tumor suppressor genes may share the same requirement, i.e., two hits are necessary to inactivate the gene function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613431      PMCID: PMC5921088          DOI: 10.1111/j.1349-7006.1996.tb00218.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

1.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome.

Authors:  N J Froggatt; J A Joyce; R Davies; D Gareth; R Evans; B A Ponder; D E Barton; E R Maher
Journal:  Lancet       Date:  1995-03-18       Impact factor: 79.321

Review 3.  Colon cancer and DNA repair: have mismatches met their match?

Authors:  J Jiricny
Journal:  Trends Genet       Date:  1994-05       Impact factor: 11.639

Review 4.  Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review.

Authors:  H T Lynch; T C Smyrk; P Watson; S J Lanspa; J F Lynch; P M Lynch; R J Cavalieri; C R Boland
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

5.  Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.

Authors:  A Hemminki; P Peltomäki; J P Mecklin; H Järvinen; R Salovaara; M Nyström-Lahti; A de la Chapelle; L A Aaltonen
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

6.  Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis.

Authors:  J Wijnen; H Vasen; P M Khan; F H Menko; H van der Klift; C van Leeuwen; M van den Broek; I van Leeuwen-Cornelisse; F Nagengast; A Meijers-Heijboer
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  Genetic instability occurs in the majority of young patients with colorectal cancer.

Authors:  B Liu; S M Farrington; G M Petersen; S R Hamilton; R Parsons; N Papadopoulos; T Fujiwara; J Jen; K W Kinzler; A H Wyllie; B Vogelstein; M G Dunlop
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

9.  Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.

Authors:  P Peltomäki; R A Lothe; L A Aaltonen; L Pylkkänen; M Nyström-Lahti; R Seruca; L David; R Holm; D Ryberg; A Haugen
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

10.  Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.

Authors:  L A Aaltonen; P Peltomäki; J P Mecklin; H Järvinen; J R Jass; J S Green; H T Lynch; P Watson; G Tallqvist; M Juhola
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

View more
  12 in total

1.  Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent.

Authors:  S E Andrew; M McKinnon; B S Cheng; A Francis; J Penney; A H Reitmair; T W Mak; F R Jirik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 2.  Two hits revisited again.

Authors:  I P Tomlinson; R Roylance; R S Houlston
Journal:  J Med Genet       Date:  2001-02       Impact factor: 6.318

3.  Evaluation of reported pathogenic variants and their frequencies in a Japanese population based on a whole-genome reference panel of 2049 individuals.

Authors:  Yumi Yamaguchi-Kabata; Jun Yasuda; Osamu Tanabe; Yoichi Suzuki; Hiroshi Kawame; Nobuo Fuse; Masao Nagasaki; Yosuke Kawai; Kaname Kojima; Fumiki Katsuoka; Sakae Saito; Inaho Danjoh; Ikuko N Motoike; Riu Yamashita; Seizo Koshiba; Daisuke Saigusa; Gen Tamiya; Shigeo Kure; Nobuo Yaegashi; Yoshio Kawaguchi; Fuji Nagami; Shinichi Kuriyama; Junichi Sugawara; Naoko Minegishi; Atsushi Hozawa; Soichi Ogishima; Hideyasu Kiyomoto; Takako Takai-Igarashi; Kengo Kinoshita; Masayuki Yamamoto
Journal:  J Hum Genet       Date:  2017-12-01       Impact factor: 3.172

4.  Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences.

Authors:  T Fujiwara; J M Stolker; T Watanabe; A Rashid; P Longo; J R Eshleman; S Booker; H T Lynch; J R Jass; J S Green; H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

5.  Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas.

Authors:  Marjo van Puijenbroek; Anneke Middeldorp; Carli M J Tops; Ronald van Eijk; Heleen M van der Klift; Hans F A Vasen; Juul Th Wijnen; Frederik J Hes; Jan Oosting; Tom van Wezel; Hans Morreau
Journal:  Fam Cancer       Date:  2008-04-15       Impact factor: 2.375

6.  Genetic screens to identify pathogenic gene variants in the common cancer predisposition Lynch syndrome.

Authors:  Mark Drost; Anne Lützen; Sandrine van Hees; Daniel Ferreira; Fabienne Calléja; José B M Zonneveld; Finn Cilius Nielsen; Lene Juel Rasmussen; Niels de Wind
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

7.  Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instability.

Authors:  Anna De Grassi; Cinzia Segala; Fabio Iannelli; Sara Volorio; Lucio Bertario; Paolo Radice; Loris Bernard; Francesca D Ciccarelli
Journal:  PLoS Biol       Date:  2010-01-05       Impact factor: 8.029

8.  Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.

Authors:  Katarina Zavodna; Tomas Krivulcik; Maria Gerykova Bujalkova; Tomas Slamka; David Martinicky; Denisa Ilencikova; Zdena Bartosova
Journal:  BMC Cancer       Date:  2009-11-20       Impact factor: 4.430

9.  Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population.

Authors:  Fulan Hu; Dandan Li; Yibaina Wang; Xiaoping Yao; Wencui Zhang; Jing Liang; Chunqing Lin; Jiaojiao Ren; Lin Zhu; Zhiwei Wu; Shuying Li; Ye Li; Xiaojuan Zhao; Binbin Cui; Xinshu Dong; Suli Tian; Yashuang Zhao
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

Review 10.  Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites.

Authors:  Powell Perng; Michael Lim
Journal:  Front Oncol       Date:  2015-07-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.